| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |